Immunomedics Inc. (IMMU) Dividend History

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.

Last update 09/24/2020


Dividend Yield Summary

  2015 2016 2017 2018 2019 2020
Dividends - - - - - -
Average Price 3.34 2.92 8.48 20.02 15.88 28.80
Yield - - - - - -
• The above Dividend, Average Price, and Yield values for 2020 are year-to-date.

Dividend History

No history of dividends
Date Amount Per Share Note